See also this year's filing and all EDGAR filings for this company.
PDF Report 0001805387_2023_Cerevel_Therapeutics_Holdings_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100060 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2': 4, '100070 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 10}} |
Graph
Absolute values for 0001805387, Cerevel Therapeutics Holdings Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 905,651,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 27,467,000 |
| 3 | remainder_Assets | 84,704,000 |
| 4 | LiabilitiesCurrent | 72,564,000 |
| 5 | LiabilitiesNoncurrent | 31,190,000 |
| 6 | remainder_Liabilities | 392,830,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 87,589,000 |
| 9 | ResearchAndDevelopmentExpense | 280,259,000 |
| 10 | remainder_Expenses | 160,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 16,497,000 |
| 13 | remainder_ComprehensiveNetIncome | 4,083,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,017,822,000 |
| 1 | Liabilities | 496,584,000 |
| 2 | Expenses | 368,008,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 521,238,000 |
| 5 | NetIncome | -351,511,000 |
| 6 | ComprehensiveNetIncome | -349,469,500 |
| 7 | BaseVar | 951,497,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.04 |
| 9 | EconomicCapitalRatio | 2.33 |
Edgar->Model Mapping
Feature Distribution
